BioGaia

Regulatory Filings • Mar 22, 2010

Press Release 22nd of March 2010

BioGaia signs agreement with pharmaceutical company in Indonesia

The agreement with the Indonesian pharmaceutical company Interbat refers to sales of BioGaia Probiotic drops in Indonesia under the BioGaia brand. Launch is estimated during the first quarter of 2011.

– We are very much looking forward to the cooperation with Interbat. The company has a strong local position and regularly visits paediatricians, who are the target group for our probiotic drops, says Peter Rothschild, President, BioGaia AB.

Interbat is the seventh largest pharmaceutical company in Indonesia with 1 500 employees. Most of their business is manufacturing and sales of their own prescription and over the counter pharmaceuticals. The representatives from Interbat regularly visit some 30 000 medical doctors in Indonesia and Interbat is represented in 1 200 of Indonesian hospitals. Of the 900 Interbat representatives around 700 will sell the BioGaia Probiotic drops.

Indonesia has 230 million inhabitants and the knowledge of probiotics is fairly high among the general public. The potential for the market is therefore estimated as large despite the relatively low level of income in the country. BioGaia Probiotic tablets are already on the market in Indonesia through the pharmaceutical company Kalbe Farma.

Latest press releases from BioGaia:

2010-03-18 BioGaia signs agreement with Ferring Pharmaceuticals in Argentina 2010-02-22 BioGaia AB Year-end report 2009 2010-02-19 BioGaia signs exclusive dealership agreement with Nippon Access

For additional information contact:

Peter Rothschild, President, telephone: +46 8 -555 293 00 Jan Annwall, Executive Vice President, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com